The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.25
Bid: 3.20
Ask: 3.30
Change: 0.00 (0.00%)
Spread: 0.10 (3.125%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.25
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK MIDDAY BRIEFING: Telecity Gains On Interxion All-Share Takeover

Wed, 11th Feb 2015 12:41

LONDON (Alliance News) - Telecity Group soared to the top of the FTSE 250 Wednesday after it said it has agreed a takeover of European data centre services provider Interxion Holding in an all-share deal, and it posted a lower profit for 2014 due to exceptional costs while planning a share buyback programme.

The data centre operator will acquire New York Stock Exchange-listed Interxion in an all-share deal, with Interxion shareholders receiving 2.3386 new Telecity shares per Interxion share. Telecity said this implies a 15% premium to the Interxion share price of USD26.47 per share as at close of business Monday.

Telecity shareholders will own around 55% of the combined group. The combined company will be primarily listed in London, with an NYSE listing for Telecity's existing American Depositary Receipt programme contemplated.

Interxion is headquartered in the Netherlands, and provides carrier-neutral data center services through 39 data centers in 11 European countries.

John Hughes, chairman of Telecity, will chair the combined company with Interxion Chairman John Baker acting as deputy chairman. Interxion's Chief Executive David Ruberg will take up the role of chief executive for a year following the completion of the deal.

Telecity said the deal is expected to be broadly neutral to earnings in its first full year, and add to earnings thereafter.

"Opinion will polarise on whether this is a product of weakness or a great opportunity to gain scale," Investec analyst Roger Phillips says of the deal.

The deal comes after Reuters reported that Telecity is understood to have become a target for private equity investors since the surprise resignation of Chief Executive Michael Tobin last October. Citing two sources familiar with the matter, Reuters reported that Telecity is understood to have attracted the attention of US and European private equity funds.

Also Wednesday, Telecity posted a pretax profit of GBP59.7 million for 2014, down from GBP65.2 million the year before, despite seeing revenue rise to GBP348.7 million from GBP325.6 million, mostly as a result of GBP18.5 million in exceptional costs, including a GBP12.0 million impairment related to its Turkish businesses.

Telecity proposed a final dividend of 9.0 pence per share, taking its total dividend to 13.5 pence compared to 10.5 pence a year before. The company said that it plans to continue a progressive dividend policy, with the aim of moving towards a 50% pay-out ratio within three years, and will also begin a GBP400 million share buyback programme covering the same period.

Shares in Telecity are trading up 13% at 960.00 pence at midday.
----------
Markets: London shares are lower, as investors digest a flurry of corporate announcements while awaiting the outcome of negotiations between Greece and European authorities over the country's debt programme. Futures are pointing to a weak open for Wall Street. The DJIA is pointed down 0.2%, the S&P 500 down 0.1% and the Nasdaq 100 flat.

FTSE 100: down 0.4% at 6,803.75
FTSE 250: down 0.2% at 16,623.50
AIM ALL-SHARE: down 0.3% at 698.15
GBP-USD: up at 1.5295
EUR-USD: down at 1.1315
GOLD: up at USD1,237.10 an ounce
OIL (Brent): down at USD55.76 a barrel
----------
Other Top Corporate News
----------
ARM Holdings posted a rise in profit for 2014, boosted by strong licence revenue growth and improved royalty revenue growth in its fourth quarter, and said it expects to meet market expectations for dollar revenues in 2015. ARM expects both its licence and royalty revenue to meet market expectations in the current year. It expects its dollar revenues in its first quarter to be up 10% compared to the previous year, based on improving royalty revenue growth. The chip designer proposed a final dividend of 4.5 pence per share, taking its total dividend for 2014 to 7.02 pence, up from a total dividend of 5.7 pence a year before.
----------
Glencore said it has revised down its capital expenditure budget for 2015 in response to "the volatile market backdrop" and said production rose across the board during 2014, as it announced it will divest its stake in Lonmin in the first half of 2015. In December, the mining and oil company had laid out a USD7.9 billion capital expenditure budget for 2015, which has now been revised down to between USD6.5 billion and USD6.8 billion. Glencore said it will divest from its 23.9% stake in platinum miner Lonmin during the first half of 2015 by distributing Lonmin shares to Glencore shareholders. Glencore acquired the stake in Lonmin through its acquisition of Xstrata in May 2013, and said it has always classed the stake as "non-core" because the company does not trade in platinum or have any "special insight" into the market.
----------
Reckitt Benckiser Group's fourth-quarter net revenue growth beat market expectations, and the group announced further cost-cutting initiatives and plans to bolster its share-buyback programme in 2015. The British consumer goods giant reported higher pretax profit for 2014 of GBP2.13 billion for 2014, compared with GBP1.86 billion in 2013. Its operating profit rose 15% to GBP2.16 billion. The figures exclude RB's pharmaceuticals business, which it spun off into new FTSE 250 constituent Indivior at the end of last year. The move left Reckitt solely focused on its consumer health and hygiene products. While profits benefited from price increases and cost optimisation initiatives, net revenue for the year came in at GBP8.84 billion, compared with a restated revenue figure of GBP9.27 billion in 2013.
----------
Indivior posted a lower pretax profit for 2014 due to generic competition in the US and price cuts in Europe hitting its revenue in the US and exceptional costs relating to the de-merger. The FTSE 250-listed pharmaceutical firm said that its outlook for 2015 is "very uncertain as to the timing, extent and impact of tablet price erosion." It is guiding net income of between USD130 million to USD155 million for 2015, on revenue of USD850 million to USD880 million. It noted however that the outcome could be higher in a more positive environment, or lower in a "very adverse scenario".
----------
Tullow Oil said it swung to a pretax loss in 2014 after booking significant impairment charges, which - combined with falling production and revenue - caused the oil exploration and production company to suspend its final dividend for the year. In an interview with Alliance News, Chief Executive Aidan Heavey said the company is focusing on retaining as much cash in the business until the middle of 2016 when its flagship TEN project in Ghana comes into production, hinting that the dividend may remain suspended over the next one to two years. Tullow swung to a USD2.04 billion pretax loss for 2014 from a USD313 million pretax profit in 2013. The loss was caused by impairment charges and losses on the company's disposal of assets, as well as lower revenue and production.
----------
GlaxoSmithKline said it has acquired the remaining stake in Switzerland based specialist vaccine company GlycoVaxyn for USD190 million. It has held a minority stake in the company since 2012, it said. The company says the acquisition will bolster its early stage vaccine pipeline, including providing it with a technology which will enable it to develop a simplified cojugated vaccine manufacturing process. GlycoVaxyn has development a biological conjugation platform technology which Glaxo says "has the potential to play an important role in the development of new prophylactic and therapeutic vaccines for a range of bacterial diseases."
----------
Capita said it has been named as the preferred bidder for the Food and Environment Research Agency joint venture by the UK Department for Environment, Food and Rural Affairs. As part of the deal, the joint venture between Capita and DEFRA has secured a long-term service agreement for up to 10 years to deliver services on behalf of DEFRA, its network and the Health and Safety Executive. The deal also includes a 10-year supplier framework under which scientific services can be bought directly by other crown bodies. Under the deal, Capita will acquire a 75% stake in the joint venture for GBP20 million in cash.
----------
The English Premier League said late Tuesday it has signed a GBP5.13 billion deal for the broadcasting rights for its football matches covering the three years from 2016 to 2019, significantly more money than analysts were expecting. Sky secured five of the seven packages available, equating to 126 live games per season from a total 168 matches, for a cost of GBP1.32 billion per year, whilst rival BT Group secured two packages, or 42 live games a season for a cost of GBP320 million per year. Sky said the price equates to an 83% increase from the cost of its existing contract, noting that it has won Friday evening games for the first time. The new deal will see Sky broadcast 126 fixtures a season compared to 116 games under its current contract. The new deal results in BT showing 42 games a season, up from its current 38 games. BT has secured a live Saturday evening game each week during the Premier League season.
----------
Ireland-based paper packaging manufacturer Smurfit Kappa Group reported a rise in pretax profit in 2014 on the back of an uptick in revenue and hiked its final dividend in response to the performance. The group reported a pretax profit of EUR378 million for the year to December 31, up from EUR294 million last year. Revenue for the year rose by 2% to EUR8.08 billion, up from EUR7.96 billion last year.
----------
Housebuilder Redrow doubled its interim dividend, as it reported its pretax profit also nearly doubled on the back of higher revenue and a rise in sales in the first half. The company said its pretax profit for the six months to the end of December was GBP91.2 million, up from GBP47.5 million last year. Revenue in the half rose to GBP560.6 million from GBP363 million, with gross margins rising to 22.4% from 20.3%. The revenue increase was also given a boost by the GBP46.8 million sale of all the commercial units and reversionary interest in the One Commercial Street development in east London. The jump in pretax profit prompted the group to double its interim dividend, up to 2 pence per share from 1 pence last year.
----------
Travel operator Thomas Cook Group said it cut its first quarter operating loss by more than 40% on the year before, as it continued to cut out costs across the business, but cited pricing and competitive pressures, and tough trading in continental Europe. Thomas Cook reported a seasonal loss before interest and taxes of GBP73 million for the three months to end-December, smaller than the GBP122 million loss it reported a year earlier. Its pretax loss for the quarter was GBP115 million, down from last year's GBP161 million loss.
----------
US private equity firm Warburg Pincus sold a larger-than-expected stake in FTSE 250-listed retailer Poundland Group, sending shares in the company lower. Warburg, its largest shareholder, sold 35 million shares in the company, nearly half its existing stake. It had planned to sell 25 million shares, but upped the placing following strong demand. Warburg sold the shares for 405 pence, raising GBP142 million. The private equity house now owns 41 million shares in the high-street discount chain, or around 16.4% of its issued share capital.
----------
Derwent London said it has struck a property swap deal with LaSalle Investment Management under which it will buy the leasehold on a property in Farringdon and will dispose of stakes in three other properties. Under the deal, Derwent will acquire a 175-year leasehold on 20 Farringdon Road in London's Tech Belt area. The passing rent is GBP3.6 million per annum or GBP3.2 million per annum net of the 10% ground rent. In return, Derwent will hand the 22 Kingsway property in central London and the Mark Square House property, in the City of London, to LaSalle.
----------
Homewares retailer Dunelm Group delivered a higher first-half profit, driven by a 14% increase in revenue helped by new store openings and strong growth online. However, the group cautioned that it expects benefits of top-line growth in the remainder of the financial year to be largely offset by higher operating costs, saying it expects to return to stronger profit growth next year. Dunelm declared a 10% increase in its interim dividend to 5.5 pence per share, and also proposed a special distribution of 70.0 pence per share.
----------
QinetiQ Group affirmed its guidance for the full year, despite continued challenges in its markets. The defence services company said its Europe, Middle East and Africa services arm is performing well and has a high level of contracted revenue for the final quarter of its financial year to the end of March, despite of uncertainty in the UK defence market related to current spending overhauls at the Ministry of Defence. But it said the performance of its Global Products business is still being impacted by reduced funding for US military operations, which has reduced demand for conflict-related products.
----------
Balfour Beatty said Philip Aiken has been appointed as its new chairman, with incumbent chair Steve Marshall to retire from the board on March 25.
----------
AIM Movers
----------
DP Poland, up 62%. The company, which sub-franchises Domino's Pizza stores in Poland, reported a jump in sales and profit in the year to the end of December. It said its system sales in the year to the end of December rose 35% to PLN20.4 million from PLN15.1 million a year earlier. Tertiary Minerals, up 13%. The company posted positive results for the phase three drilling programme at the MB fluorspar project in Nevada. Drilling at Holes 14TMBRC030, 14TMBRC032 and 14TMBRC033 all encountered fluorspar intersections and demonstration continuity of the mineralisation to the west of the central area of the prospect. Red24, up 13%. The crisis assistance company said it expects to beat expectations for the full year on the back of new business wins and a busy third quarter. ValiRx, up 10%. The life sciences company said it has been handed patent approval from the European Patent Office for a biomarker testing process. Styles & Wood Group, up 8.6%. The property services company said its full-year trading was in line with expectations on the back of a rise in revenue in the second half.

Trap Oil Group, off 57%. The company said it has relinquished its interest in one license in the UK North Sea at a cost of USD5.8 million and said it is incurring a significant loss on another field due to the low oil price environment. Tangent Communications, down 28%. The marketing platforms and services provider said that it now expects to post an underlying operating profit of GBP1.2 million for the year to end-February, down from the previous year, and said it does not expect to propose a final dividend.
----------
Top Economics And General
----------
Greek Prime Minister Alexis Tsipras vowed to renegotiate the terms of the country's debt deal on the eve of tough negotiations with its eurozone partners on Wednesday, saying there was "no turning back". "We want a new agreement that is in the mutual interest of Greece and its lenders - one which will end punishing conditions and the destruction of the Greek economy ... there is no turning back," he told parliament just before his leftist coalition-led government survived its first confidence vote. Lawmakers voted 162-137 for Tsipras' coalition government. Eurozone finance ministers are to hold an emergency meeting Wednesday before an EU summit on Thursday on the Greek crisis.
----------
Casualties mounted in eastern Ukraine, just hours before the leaders of France, Germany, Ukraine and Russia were expected to hold a peace summit in the Belarusian capital Minsk. Some 19 soldiers were killed and 79 injured during the past 24 hours, defence ministry spokesman Vladislav Seleznyov said in Kiev, according to local media. In Donetsk, the separatists said that six civilians were killed and eight injured when a rocket exploded at a bus station. The Ukrainian army denied responsibility for the attack.
----------
The G20 finance ministers and central bank governors called for accommodative monetary and fiscal policies as the global growth remains 'uneven' with subdued progress in Eurozone and Japan. According to a communique released after the two-day meeting of G20 finance ministers and central bank governors in Istanbul on Tuesday, officials expressed determination to overcome challenges to achieve the common objective of strong, sustainable and balanced growth and to add jobs and foster inclusiveness.
----------
Chinese President Xi Jinping is to pay his first state visit to the US in September, state media announced. Xi Wednesday held phone talks with US President Barack Obama where he formally accepted the latter's invitation to pay a state visit, Xinhua reported.
----------
Afternoon Watchlist (all times in GMT)

12:00 US MBA Mortgage Applications
13:00 US Fed's Richard Fisher's speech
15:30 US EIA Crude Oil Stocks
16:30 EU Eurogroup meeting
19:00 US Monthly Budget Statement
----------
Thursday's Key UK Corporate Events

Rio Tinto - Full-Year Results
Shire - Full-Year Results
Imperial Tobacco Group - Q1 Interim Management Statement
Tate & Lyle - Interim Management Statement
Lancashire Holdings - Q4 Results
Darty - Q3 Interim Management Statement
Informa - Full-Year Results
Morgan Advanced Materials - Full-Year Results
Zoopla Property Group - Interim Management Statement
---------
Thursday's Key Economic Events (all times in GMT)

All Day EU EU Extraordinary Economic Summit
00:01 UK RICS Housing Price Balance
02:00 China New Loans and M2 Money Supply
06:00 Japan Machine Tool Orders preliminary
07:00 Germany Consumer Price Index
10:00 EU Industrial Production
10:30 Bank of England Quarterly Inflation Report and Governor Carney speech
13:30 US Jobless Claims
13:30 Canada New Housing Price Index
13:30 US Retail Sales
15:00 US Business Inventories
15:30 US EIA Natural Gas Storage
---------
Contact: +44 207 199 0340; newsroom@alliancenews.com; @AllNewsTeam

Copyright 2015 Alliance News Limited. All Rights Reserved.



More News
31 Mar 2023 16:39

TRADING UPDATES: FireAngel signs with British Gas; Shanta pours gold

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
1 Mar 2023 20:09

TRADING UPDATES: Ediston signs 10-year lease with Marks & Spencer

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
1 Mar 2023 14:26

ValiRx incorporates new wholly-owned lab subsidiary

(Sharecast News) - Life science company ValiRx announced the incorporation of a new wholly-owned subsidiary, Inaphaea BioLabs, on Wednesday.

Read more
3 Feb 2023 13:41

TRADING UPDATES: Somero revenue short of outlook; SigmaRoc optimistic

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
26 Jan 2023 15:44

UK shareholder meetings calendar - next 7 days

Friday 27 January 
Avon Protection PLCAGM
Henderson Far East Income LtdAGM
Ixico PLCAGM
NB Global Monthly Income Fund LtdEGM re proposed managed wind-down
On The Beach Group PLCAGM
Pathfinder Minerals PLCGM re capital raise
Serica Energy PLCGM re consideration shares approval
Treatt PLCAGM
Monday 30 January 
Bluebird Merchant Ventures LtdAGM
Contango Holdings PLCAGM
Hollywood Bowl Group PLCAGM
SkinBioTherapeutics PLCGM re annual report review
Starwood European Real Estate Finance LtdEGM re capital return 
Webis Holdings PLCAGM
Tuesday 31 January 
Hydrogen Future Industries PLCAGM
Mobile Streams PLCAGM
Residential Secure Income PLCAGM (TBC)
Star Phoenix Group LtdGM re removal and appointment of auditor
Team PLCAGM
Yamana Gold IncSGM re transaction with Agnico Eagle Mines Ltd and Pan American Silver Corp
Zamaz PLCAGM
Wednesday 1 February 
Baronsmead Second Venture Trust PLCAGM
Baronsmead Venture Trust PLCAGM
Capricorn Energy PLCGM re directors removal and appointment of new directors
Catalyst Media GroupAGM
Hyve Group PLCAGM
Imperial Brands PLCAGM
Premier Miton Group PLCAGM
Renew Holdings PLCAGM
Schroder Asia Pacific Fund PLCAGM
Thursday 2 February 
abrdn Equity Income Trust PLCAGM
Alteration Earth PLCAGM
Baillie Gifford European Growth Trust PLCAGM
JPMorgan Indian Investment Trust PLCAGM
Sage Group PLCAGM
Schroder European Real Estate Investment Trust PLCAGM
Tectonic Gold PLCAGM
ValiRx PLCGM re fundraising
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
17 Jan 2023 21:40

TRADING UPDATES: Future Metals in JV; Gunsynd sells stake in investee

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
13 Jan 2023 13:31

IN BRIEF: ValiRx seeks up to GBP1.5 million for new research facility

ValiRx PLC - Hatfield Heath, England-based life sciences company focused on early-stage cancer therapeutics and women's health - Raises GBP1 million from placing of 9.1 million shares at 11 pence each. Also will raise up to GBP500,000 more from a broker offer to retail investors at the same price. Turner Pope Investments Ltd will run the broker offer. Every four shares in the placing and retail offer come with a warrant to buy another new share at 14p over the next three years. Calls February 2 general meeting to approve the fund raise. Currently has a GBP10.1 million market capitalisation.

Read more
6 Dec 2022 11:31

ValiRx shares fall on test extension, but optimistic of other assets

(Alliance News) - ValiRx PLC on Tuesday saw shares drop, after extending its evaluation agreement with Hokkaido University to conduct further experimental testing.

Read more
24 Oct 2022 12:47

ValiRx forms new majority-owned breast cancer subsidiary

(Sharecast News) - Women's health and cancer therapeutics company ValiRx announced the formation of a new partially-owned subsidiary, Cytolytix, on Monday, which had signed an intellectual property licence agreement with King's College London (KCL).

Read more
24 Oct 2022 10:05

ValiRx teams with King's College London for cancer project

(Alliance News) - ValiRx PLC on Monday said it is making progress on its goal to introduce new academic projects into its portfolio, after launching subsidiary company Cytolytix Ltd and signing a licence agreement with King's College London.

Read more
8 Sep 2022 11:47

IN BRIEF: ValiRx shares up on new interim chief scientific officer

ValiRx PLC - Nuneaton, England-based drug development company - Appoints Catherine Tralau-Stewart as interim chief scientific officer. Says she has experience working across leading pharmaceutical companies and academic groups. Tralau-Stewart will review new, incoming science; enhance the progress of existing projects; and influence the overall strategic scientific direction of the company, ValiRx adds. Chief Executive Suzy Dilly comments: "I'm looking forward to having another in-house scientist with whom to share ideas and to develop and deliver upon our strategic ambitions. Cathy's wealth of experience in exactly the areas in which we wish to progress, makes her an excellent choice for this role."

Read more
31 Aug 2022 13:51

EARNINGS UPDATES: Windward widens loss as operating expenses rise

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
13 Jul 2022 14:44

IN BRIEF: ValiRx shares jump on breast cancer drug candidate progress

ValiRx PLC - Nuneaton, England-based drug development company - Completes the evaluation of the impact of a peptide drug candidate against triple negative breast cancer. Evaluation concludes there is "good evidence" of biological activity and a "strong" rationale for further development. Adds that the drug candidate was investigated over nine months. Tests also demonstrate promising data on ovarian cancer cells, in addition to the targeted breast cancer cells. As a result, ValiRx has notified the academic team and intellectual property & licensing team at King's College London that it wants to proceed to full in-licensing.

Read more
5 Jul 2022 15:51

IN BRIEF:ValiRx gains GBP1.0 million from Turner Pope broker option

ValiRx PLC - Nuneaton, England-based drug development company - Announces that the broker option granted to Turner Pope Investments Ltd has been fully subscribed and raises GBP1.0 million before expenses.

Read more
30 Jun 2022 17:31

TRADING UPDATES: M&C Saatchi expects to deliver on annual profit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.